Agenus Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (40)

Latest Posts

About This Stock More About This Stock
3 Stocks Under $10 For Double-Digit Gains
Article By: Bret Jensen
Tuesday, March 29, 2016 4:10 PM EDT
Buy shares in these three companies that are about to rally from their undervalued lows. Trading for under $10 each, these stocks are much too cheap for their growth prospects: INO, SQBG and AGEN.
In this article: INO, AGEN, SQBG Also: MRK, ICON, INCY
Read
Seven Biotech Names On The Upswing: 2016 Small-Cap Biotech Watchlist Update
Article By: The Life Sciences Report
Wednesday, March 9, 2016 5:47 PM EDT
Biotech stocks—and the stock market in general—took a dive at the beginning of 2016, headed down on macroeconomic factors such as financial instability in China.
In this article: SGYP, CRMD, ORMP, SRNE, ARRY, PTIE, AGEN, GALE, PPHM, EVOK, ADMA, AKBA, KPTI, VSTM, AST, RXDX, AGTC, WVE, FATE, FLKS, PIRS, ABEO
Read
Four Homerun Biotech Stocks Too Cheap By A Half
Article By: Bret Jensen
Sunday, February 21, 2016 12:38 PM EDT
Valuations this cheap haven’t been available in biotech since 2011, and buying any of these four stocks right now could be one of your best investing decisions of 2016.
In this article: HALO, AGEN, BDSI, EGRX, INCY, GILD, ABBV Also: MRK, ENDP, TEVA
Read
The 2016 Small-Cap Biotech Watchlist Debuts At The Biotech Showcase
Article By: The Life Sciences Report
Wednesday, January 27, 2016 6:16 PM EDT
This may prove a challenging year for small-cap biotechs, but the five analysts who selected companies for inclusion on The Life Sciences Report's 2016 Small-Cap Biotech Watchlist believe these companies have a good producing value for investors.
In this article: AZN, NVO, SGYP, SNY, CRMD, ORMP, CMXHY, SRNE, ALNY, ARRY, INCY, IRWD, PTIE, REGN, VRTX, AGEN, GALE, GRFS, PPHM, EVOK, ADMA, AKBA, VSTM, AST, RXDX, AGTC, NK, WVE, FATE, FLKS
Read
Top 3 Biotech Takeover Targets To Buy
Article By: Bret Jensen
Saturday, January 2, 2016 4:47 PM EDT
I will bet that 2016 will bring a reversion to the mean and small cap equities will once again outperform their larger brethren. Here are several small cap selections that should do very well in 2016 should that indeed occur.
In this article: AGEN, ANIP, RLYP Also: MRK, VRX, INCY, TEVA, ZSPH, ADRO, AZN, GSK
Read

PARTNER HEADLINES

Latest Tweets for $AGEN

No tweets yet!